492,00 plus VAT


Anti-CD112R (HU) from Mouse (clone R12) – 100 µl


Cat.No. DIA-R12
Specificity CD112R
Species Reactivity Human
Host Species Mouse
Isotype IgG1/k
Clone R12
Immunohistochemistry (IHC),
Formalin-fixed Paraffin-embedded sections (FFPE)
Western Blot
Conjugation unconjugated
Dilution IHC 1:100-1:200
Antibody purified (from culture supernatant)
Quantity 100µl
Positive control Tonsil
Presentation PBS pH 7.4, 2%BSA, 0.05%NaN3
BSA-free high conc. variant available upon request
Intended Use Research Use Only
Manufacturer / Brand ONCOdianova
CD112R IHC-Gallery
IHC-figures on CD112R detection in different tumors.


Anti-PVRIG/CD112R clone R12 has been developed for detection of CD112R in routine formalin-fixed paraffin-embedded tissue specimen (IHC FFPE) to be used in bright field immunohistochemistry and moreover for multicolor immunofluorescence (fluorescence multiplex IHC). Anti-PVRIG/CD112R clone R12 has been validated for sensitivity and specificity on large quantities of normal and tumor tissues. Clone R12 displays no background in non lymphoid cells and in epithelial cells. Based on the high specificity combined with an inherent high signal to noise ratio clone R12 is ideally suited for multiplexed immunohistochemistry studies of CD112R in human tissue specimen.

CD112R, a member of poliovirus receptor–like proteins, is preferentially expressed on T-cells and inhibits T-cell receptor mediated signals. Blockade of the CD112R-CD112 interaction enhances T cell response. CD112R binds to its ligand CD112 which is widely expressed on antigen-presenting cells and on tumor cells. CD112R competes with CD226 to bind to CD112 and thereby acts as a coinhibitory receptor for T cells. Blockage of the CD112R–CD112 interaction enhances human T cell response.

TIGIT and CD226 constitute a T cell cosignaling pathway in which CD226 and TIGIT, respectively, serve as costimulatory and coinhibitory receptors for the ligands CD155 and CD112. This TIGIT signaling axis includes a complex receptor ligand system with the marker CD112R, which has become a promising target in cancer immuno-therapy.

IHC protocols

Staining protocols for anti-human CD112R antibody clone R12
Cat.No.: DIA-R12
Isotype: Mouse IgG1/k
Specificity: Human CD112R / PVRIG
Physical State: Lyophilized powder
Reconstitution: DIA-R12, restore to 100µl. Reconstitute with sterile destilled water by gentle shaking for 10 minutes.
Manual stain with autoclave
  • Pretreatment buffer: 121°C / 5 min / pH7,8
  • Incubation primary antibody: 60 min / 37°C (Dilution: 1:150)
  • Envision HRP rabbit/mouse: 30 min / 37°C
Applicaple for automated staining procedures and validated for mulitcolor immunofluorescence (multiplexed IHC).


Specific references from the American Association of Cancer Research (AACR) annual meeting 2020
Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA, Volume 80, Issue 16 Supplement, pp. 3870 and pp. 4970

Abstract 3870:
Patterns of CD112R expression in normal lymphatic tissues, inflammation and cancer

Abstract 4970:
Prognostic role of CD112R, PD-1 and Ki67 expression in CD8+cytotoxic T cells in colorectal cancer


CD112R IHC-Gallery
IHC-figures on CD112R detection in different tumors.

You may also like…